Position in ALKS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,352,576
+$459,418 QoQ
Shares Held
25,815
+2.2% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#35
of 146 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $10,662,030 across 14 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
184,502 | $1,721,403 | |
| 2 | ALKS |
Alkermes plc.
This page
|
25,815 | $1,352,576 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
35,789 | $1,212,531 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
47,850 | $1,177,588 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
17,744 | $838,758 | |
| 6 | ZTS |
Zoetis Inc.
|
11,360 | $816,329 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
41,957 | $672,570 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
562,423 | $641,162 |
All Filings in ALKS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,352,576 | 25,815 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $893,158 | 25,259 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $710,775 | 25,403 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $808,380 | 26,946 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $695,623 | 24,314 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $687,212 | 20,812 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $682,244 | 23,722 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $559,380 | 19,985 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $435,511 | 18,071 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||